Medical News Observer

Overview of OptimMRI

OptimMRI represents an advancement in medical imaging technology, particularly in neurosurgery. Developed by RebrAIn, SAS, this software application specializes in processing brain magnetic resonance (MR) images for 3D visualization and analysis. The core functionality of OptimMRI lies in its ability to interpret DICOM-compatible pre-operative MR images from various imaging devices. This capability is crucial for medical professionals who rely on detailed brain imagery for neurosurgical planning and execution.

Key Features:

• 3D Visualization: OptimMRI transforms conventional MR images into detailed 3D models, enhancing understanding of complex brain structures.
• Anatomical Analysis: It allows for the analysis of specific brain regions, aiding in accurately localizing areas like the Subthalamic Nuclei (STN) and Ventral Intermediate Nucleus (VIM).
• User Interaction: Medical professionals can interact with the 3D models by displaying, reviewing, annotating, and exporting data for comprehensive analysis.
• Surgical Planning: The software allows for planning neurosurgical procedures, particularly functional neurosurgery.

Indications and Usage

OptimMRI is a tool designed for qualified medical professionals, providing capabilities in processing and interpreting brain anatomy from medical images. Its primary application is in neurosurgical planning, where precise localization of brain structures is vital. The software’s ability to generate annotated 3D models of the brain makes it an indispensable tool in the pre-operative stage, complementing other clinical methods for targeting regions like the Subthalamic Nuclei (STN) and Ventral Intermediate Nucleus (VIM).

Safety and Performance

The safety and accuracy of OptimMRI have been thoroughly evaluated through comparative studies with existing software tools. In studies involving cerebral MRIs, experienced medical professionals used OptimMRI for segmentation tasks related to the Subthalamic Nuclei (STN) and Ventral Intermediate Nucleus (VIM):

• Comparative Analysis: The software’s performance was benchmarked against established devices like Guide XT and SureTune4.
• Accuracy Metrics: The studies demonstrated that surface distances of Subthalamic Nuclei (STN) and Ventral Intermediate Nucleus (VIM) segmented by OptimMRI were within a 2.0mm range, aligning with the standards of comparable tools.
• Safety Profile: No new safety or efficacy concerns were identified, affirming that OptimMRI is on par with, if not superior to, existing devices in terms of safety and functionality.

Regulatory Approval

OptimMRI obtained premarket authorization from the FDA on July 21st, 2023.

Ref: https://www.accessdata.fda.gov/cdrh_docs/pdf23/K230150.pdf